Bilateral function of Mdm2 in the carcinogenesis and progression of hepatocellular carcinoma.

被引：0
|
作者：
Makino, Yuki [1 ]
Hikita, Hayato [1 ]
Kodama, Takahiro [1 ]
Kai, Yugo [1 ]
Nozaki, Yasutoshi [1 ]
Nakabori, Tasuku [1 ]
Saito, Yoshinobu [1 ]
Sakamori, Ryotaro [1 ]
Tatsumi, Tomohide [1 ]
Takehara, Tetsuo [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1846
引用
收藏
页码：981A / 981A
页数：1
相关论文
共 50 条
  • [1] MDM2 antagonists - a therapeutic approach for patients with hepatocellular carcinoma?
    Mahdi, A.
    Lunec, J.
    Reeves, H.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S44 - S44
  • [2] MDM2 function
    Lozano, G.
    Montes de Oca Luna, R.
    B B A - Biomembranes, 1377 (02):
  • [3] MDM2 function
    Lozano, G
    Luna, RMD
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1998, 1377 (02): : M55 - M59
  • [4] MDM2 expression and p53 mutation in renal cell carcinoma.
    Warburton, HE
    Parsons, KF
    Linehan, WM
    Boyd, MT
    JOURNAL OF UROLOGY, 2005, 173 (04): : 104 - 104
  • [5] Overexpression of p53 and MDM2 in salivary gland adenoid cystic carcinoma.
    Jia, L
    Tang, XF
    Esguerra, RL
    Okada, N
    Takagi, M
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A300 - A300
  • [6] Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma
    Endo, K
    Ueda, T
    Ohta, T
    Terada, T
    LIVER, 2000, 20 (03): : 209 - 215
  • [7] Analysis of immune landscape in hepatocellular carcinoma patients with MDM2/4 mutations
    Wang, Xinjun
    Zhang, Hushan
    Yang, Yuan
    Du, Hang
    Tang, Jingling
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Functional association of MDM2 binding protein with metastatic potential of hepatocellular carcinoma
    Bi, Qian
    Tang, Shanhong
    Fan, Rui
    Agarwal, Neeraj
    Shi, Yongquan
    Iwakuma, Tomoo
    Ding, Jie
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 609 - 610
  • [9] Angiopoietin/TIE2 signaling in progression of hepatocellular carcinoma.
    Tanaka, S
    Sugimachi, K
    Yamashita, YI
    Maehara, SI
    Shirabe, K
    Shimada, M
    Wands, JR
    Maehara, Y
    HEPATOLOGY, 2002, 36 (04) : 238A - 238A
  • [10] CCAT2 contributes to hepatocellular carcinoma progression via inhibiting miR-145 maturation to induce MDM2 expression
    Niu, Chao
    Wang, Linlin
    Ye, Weijian
    Guo, Shikun
    Bao, Xiaozhou
    Wang, Yongbiao
    Xia, Zhaobo
    Chen, Randong
    Liu, Chong
    Lin, Xiaokun
    Huang, Xiaozhong
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (09) : 6307 - 6320
12345